Alarming colistin and carbapenem resistance in Klebsiella pneumoniae: molecular insights from Tehran hospitals, Iran

伊朗德黑兰医院的分子研究表明,肺炎克雷伯菌对粘菌素和碳青霉烯类抗生素的耐药性令人担忧。

阅读:1

Abstract

OBJECTIVE: An alert has been issued regarding the widespread emergence of multidrug-resistant (MDR) and carbapenem-resistant Klebsiella pneumoniae (CRKP) in hospital settings. A total of 150 consecutive, non-duplicate K. pneumoniae isolates were obtained from patients admitted to tertiary care hospitals in Tehran between April 2023 and December 2024. These isolates were cultured from various clinical specimens, including sputum, urine, blood, wounds, bronchoalveolar lavage, and tracheal swabs. Antimicrobial susceptibility testing was performed using both disk diffusion and microdilution methods according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Additionally, combined disk diffusion test (CDDT), modified carbapenem inactivation method (mCIM), and EDTA-modified carbapenem inactivation method (eCIM) tests were used to confirm the production of extended-spectrum β-lactamases (ESBLs), carbapenemases, and metallo-β-lactamases (MBLs), respectively. Biofilm production was assessed using the microtiter plate method with crystal violet staining. Molecular detection of ESBL genes (bla(TEM), bla(SHV), bla(CTX-M), bla(GES), bla(PER), bla(VEB)), carbapenemase/MBL genes (bla(NDM), bla(VIM), bla(IMP), bla(KPC), bla(OXA-48)), and colistin resistance genes (mcr-1 to mcr-4) was performed by PCR sequencing. RESULTS: Colistin showed the highest efficacy, with susceptibility rates of 83.3%. Notably, 25 isolates (16.7%) were colistin-resistant and 115 (76.7%) were carbapenem-resistant. Phenotypic analysis identified 87 (57.3%) isolates as ESBL producers, 93 (62%) as carbapenemase producers, and 79 (52.7%) as MBL producers. Biofilm production levels were categorized as strong (44 isolates, 29.3%), moderate (56, 37.3%), and weak (50, 33.3%). The spectrum of detected resistance genes included bla(TEM) (117, 78%), bla(SHV) (74, 49.3%), bla(CTX-M) (121, 80.7%), bla(NDM) (71, 47.3%), bla(OXA-48) (44, 29.3%) and bla(VIM) (4, 2.7%), whereas bla(GES), bla(PER), bla(VEB), bla(IMP), bla(KPC), and mcr-1 to mcr-4 genes were not detected in any isolates. These findings underscore the critical need for comprehensive surveillance and stringent infection control measures to prevent the spread of resistant K. pneumoniae strains in healthcare facilities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。